Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE (www.oxfordhandbooks.com). © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 16 November 2019

Abstract and Keywords

In this chapter the neuroscientific basis and clinical rationale of cognitive psychopharmacology are reviewed. Effects of drugs in humans and animals are surveyed on different forms of memory and a number of aspects of executive function, including attention, working memory, cognitive flexibility, and response inhibition. The main drug classes covered include the benzodiazepines and the stimulants, but their cognitive effects are mainly analyzed in terms of their neurochemical modes of action, for example, at GABAergic, glutamatergic, monoaminergic, or cholinergic receptors, and in relation to their neuroanatomical sites. Particular attention is paid to cognitive-enhancing drugs and their prospects. The main factors determining the benefits and costs of drugs on cognitive performance are identified. The utility of psychopharmacology in dissecting cognitive processes is also considered.

Keywords: memory, executive function, attention, neurotransmitter, cognitive enhancement

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.